Rigel Pharmaceuticals, Inc. (RIGL)
46.18
-0.30
(-0.66%)
USD |
NASDAQ |
Aug 31, 16:00
46.18
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash and Short Term Investments (Quarterly) : 95.33M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.33M |
| March 31, 2026 | 146.68M |
| December 31, 2025 | 154.96M |
| September 30, 2025 | 137.14M |
| June 30, 2025 | 108.38M |
| March 31, 2025 | 77.10M |
| December 31, 2024 | 77.32M |
| September 30, 2024 | 61.11M |
| June 30, 2024 | 49.10M |
| March 31, 2024 | 49.55M |
| December 31, 2023 | 56.93M |
| September 30, 2023 | 62.35M |
| June 30, 2023 | 64.36M |
| March 31, 2023 | 58.66M |
| December 31, 2022 | 58.21M |
| September 30, 2022 | 81.64M |
| June 30, 2022 | 89.17M |
| March 31, 2022 | 107.52M |
| December 31, 2021 | 124.97M |
| September 30, 2021 | 143.15M |
| June 30, 2021 | 153.39M |
| March 31, 2021 | 39.34M |
| December 31, 2020 | 57.33M |
| September 30, 2020 | 72.81M |
| June 30, 2020 | 92.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 95.93M |
| December 31, 2019 | 98.08M |
| September 30, 2019 | 107.48M |
| June 30, 2019 | 112.38M |
| March 31, 2019 | 127.92M |
| December 31, 2018 | 128.54M |
| September 30, 2018 | 115.64M |
| June 30, 2018 | 134.99M |
| March 31, 2018 | 94.30M |
| December 31, 2017 | 115.75M |
| September 30, 2017 | 68.08M |
| June 30, 2017 | 82.30M |
| March 31, 2017 | 98.14M |
| December 31, 2016 | 74.77M |
| September 30, 2016 | 85.26M |
| June 30, 2016 | 94.94M |
| March 31, 2016 | 103.63M |
| December 31, 2015 | 126.28M |
| September 30, 2015 | 134.35M |
| June 30, 2015 | 143.94M |
| March 31, 2015 | 161.16M |
| December 31, 2014 | 143.16M |
| September 30, 2014 | 157.67M |
| June 30, 2014 | 176.03M |
| March 31, 2014 | 195.38M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 79.13M |
| Cytokinetics, Inc. | 1.169B |
| Perspective Therapeutics, Inc. | 236.88M |
| Capricor Therapeutics, Inc. | 237.93M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |